Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that affects mainly females. What role the X chromosome plays in the disease has always been an intriguing question. In this study, we examined the genetic variants on the X chromosome through meta-analysis of two genome-wide association studies (GWAS) on SLE on Chinese Han populations. Prominent association signals from the meta-analysis were replicated in four additional Asian cohorts, with a total of 5, 373 cases and 9, 166 matched controls. We identified a novel variant in PRPS2 on Xp22.3 as associated with SLE with genome-wide significance (rs7062536, OR=0.84,
ABSTRACT:
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that affects mainly females. What role the X chromosome plays in the disease has always been an intriguing question. In this study, we examined the genetic variants on the X chromosome through meta-analysis of two genome-wide association studies (GWAS) on SLE on Chinese Han populations. Prominent association signals from the meta-analysis were replicated in four additional Asian cohorts, with a total of 5, 373 cases and 9, 166 matched controls. We identified a novel variant in PRPS2 on Xp22.3 as associated with SLE with genome-wide significance (rs7062536, OR=0.84,
P=1.00E-08). Association of the L1CAM-MECP2 region with SLE was reported
previously. In this study, we identified independent contributors in this region in NAA10 (rs2071128, OR=0.81, P=2. 19E-13) and TMEM187 (rs17422, OR =0.75, P= 1.47E-15), in addition to replicating the association from IRAK1-MECP2 region (rs1059702, OR=0.71, P=2. 40E-18) in Asian cohorts. The X-linked susceptibility variants showed higher effect size in males than in females, similar to results from a genome-wide survey of associated SNPs on the autosomes. These results suggest that susceptibility genes identified on the X chromosome, while contributing to disease predisposition, might not contribute significantly to the female predominance of this prototype autoimmune disease.
Introduction:
Systemic lupus erythematosus (SLE) is an autoimmune disease with an overwhelming female predominance. Women of child bearing age are most affected, though pre-menstrual and post-menopausal women also have higher prevalence than males of the same age group (1, 2) . The X chromosome certainly plays a role in SLE risk and prevalence, as demonstrated by many functional and susceptibility variants identified on the X chromosome (3) (4) (5) (6) (7) . Interestingly, men with Klinefelter syndrome (XXY) have much higher disease prevalence than normal XY males (8) , suggesting a dosage effect of the X chromosome genes in disease pathogenesis.
The mechanism through which X linked genes contributes to female disease prevalence is poorly understood. In healthy women, one X chromosome is inactivated in a process known as X chromosome inactivation (XCI), to compensate for the dosage difference between the two genders. In this process, Xist, a long noncoding RNA, coats the chromosome to be inactivated and recruits other proteins to the X chromosome, leading to its silencing (9) . It is now known that X chromosome is only partially inactivated under physiological conditions. About 10-15% of the genes may be expressed by both X chromosomes in female cells, thus leading to incomplete dosage compensation with a higher expression level than in males (10) . Female cells are mosaic for X linked genes due to the random process of XCI. Skewed X inactivation refers to preferential expression of either maternal or paternal allele in majority of cells in a tissue and is thought to play a role in autoimmunity (11) .
One particular question on the role of X chromosome genes in autoimmune diseases is that whether susceptibility genes on the X chromosome have more contribution towards the disease in females than in males, potentially through escaping dosage compensation with increased expression, or through skewed XCI with risk alleles expressed in most of female cells, leading to more females being affected by the risk allele (both homozygous and heterozygous genotypes) than males. Comparing the effect size of susceptibility variants in homozygous, heterozygous females and hemizygous males may shed light on the mechanism through which X-linked genes contribute to female disease prevalence. If the susceptibility genes are involved in escaping XCI or are involved in skewed X inactivation towards the risk allele, then the susceptibility variant may demonstrate a much larger effect size in females than in males or they may follow a near dominant rather than additive model of disease association.
Tukiainen et al (12) studied association of more than 400,000 X chromosome SNPs to levels of twelve cardiometabolic and anthropometric traits on Finnish and Swedish individuals and identified three loci with association of genome-wide significance.
Interestingly, the SNP in a locus near ITM2A associated with height showed a clear lack of dosage compensation, with estimated effect size twice as much in women as in men. For the other two loci, the proportion of variance explained was roughly twice the size in men as in women, as expected under the model of random XCI, different from the SNP in ITM2A, which showed a much higher variance explained in women than in men. Consistent with the genetic findings, they observed significantly higher expression of ITM2A in whole blood in women.
It is known that promoters on the X chromosome to be silenced are often heavily methylated (10) . In SLE patients, however, this process might be compromised. For example, DNA methylation was found to be defective in CD4+ T cells in patients with lupus (13, 14) , and hypomethylation in these cells might lead to overexpression of genes that are important in SLE pathogenesis (15, 16) . Several X-linked genes including CD40LG were found to be overexpressed in female patients with SLE but not in male patients (17, 18) . CXCR3, OGT and microRNAs such as miR-98, miR188-3p, miR-421 and miR-503 were also found overexpressed in T cells in female but not male patients (16) . This aberrant lack of methylation and gender-specific overexpression of genes might play important roles in female predominance of the disease.
A number of X-linked genes have been reported to be associated with SLE (3) (4) (5) (6) . A SNP on the 3'-UTR of TLR7 was shown to be associated with SLE in different ancestral groups, with higher effect size in males than in females (5) . IRAK1 and MECP2 were reported to be associated with SLE by two independent studies using a candidate gene approach (3, 4) . These two genes are physically close to each other and the strong linkage disequilibrium (LD) in this region led to a debate on which gene could be responsible for disease susceptibility (19) . In a recent study (6), Kaufman et al concluded that a nonsynonymous SNP rs1059702 (S196F) in IRAK1 might be the causal variant in this region. The Xq28 region also has been suggested to be involved in several autoimmune diseases including rheumatoid arthritis (RA) (20) and systemic sclerosis (SSc) (21) . Interestingly, though rs1059702 was reported in each study, in both cases there are other SNPs in this region forming risk haplotypes with rs1059702, suggesting existence of independent contributors in this region.
In the current study, meta-analysis was first performed on two GWAS data on Chinese populations on the X chromosome and potential association signals were followed up by replication in independent cohorts. We confirmed the association of the Xq28 region with SLE and identified independent variants centromeric to this region, as well as a novel susceptibility variant in PRPS2 located on Xp22.2. The susceptibility variants on the X-chromosome showed a higher effect size in males than in females, with no evidence of lack of dosage compensation. Higher cumulative genetic risk in affected males was also observed in a genome-wide survey.
Results

X chromosome imputation and meta-analysis
Our study comprised two sets of GWAS data with a total of 612 cases and 2193 controls from the Hong Kong GWAS, and 1047 and 1205 controls from the GWAS conducted in Anhui, China. Based on the fact that 90% of the cases were females and the gender difference in X-chromosome dosage, we first focused only on female samples, analyzing a total of 559 cases and 1,274 controls, and 984 cases and 532 controls from Hong Kong and Anhui, respectively. Meta-analysis of the two GWAS datasets was conducted using the inverse variance method installed in METAL (22) . Q-Q plots ( Fig. 1) showed a clear deviation at the tail from the diagonal line for both cohorts and the meta-analysis, suggesting existence of susceptibility variants on the X-chromosome and consistencies between the two cohorts.
Imputation of the X chromosome SNPs was performed on the two GWAS data on both male and female samples, using data from 1000 Genomes project as references.
Association analysis was carried out by SNPTEST(23), using sex as a covariate to correct for potential gender differences. Meta-analysis of imputed data showed that there were 284 SNPs reached P _meta< 10 -3 . Two SNPs were removed due to inconsistent association direction between the two studies. Summary statistics of all the X-linked SNP after imputation swere made available to the public for further exploration in future studies (Supplementary Material, Table S1 ) and more detailed information on the X-chromosome variants will be provided upon request. The two GWAS datasets were subsequently assessed for population stratification using EIGENSTRAT (24) . Statistical significance of the SNPs was re-assessed using SNPTEST, using the first two most prominent principal components to correct for potential population stratification (P_adj in Supplementary Material, Table S1 ).
Comparing P_meta (without adjustment using PC as covariates) and P_adj values, it can be seen that there was no substantial difference before and after applying the correction using PCs. No imputed SNPs, however, showed better P values or convincing predicted functional implications that would warrant further replication on top of the genotyped SNPs. Based on the P value in each cohort and the LD information, 11 SNPs from three regions near or in VCX2 (1 SNP), PRPS2 (1 SNP), and L1CAM1-MECP2 (9 SNPs) were selected for further replication in independent cohorts.
Replication and further analysis of selected SNPs
Further replication of the selected SNPs was performed by Sequenom or TaqMan combined P values and ORs were calculated using logistic regression where gender and cohort information were used as covariates ( Table 1) . 
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Independence test of the replicated SNPs in the L1CAM-MECP2 region
The independent contribution of each SNP in this region to disease susceptibility was further examined. Pairwise independence tests of the nine SNPs were performed by logistic regression, also considering potential subpopulation and gender differences ( Table 2) . It is noted that the three haplotype blocks roughly defined by r 2 values shown in Fig. 2 each had independent contributions towards disease susceptibility.
Three representative SNPs of these blocks, rs2071128, rs17422 and rs1059702
showed consistent significance after adjusting for the effect of other individual SNPs in different LD blocks. A stepwise logistic regression analysis was also performed to test independence of these SNPs ( Table 3 ). This analysis showed that rs1059702 exhibited the strongest association with SLE (P=2.27E-08). Subsequent addition of rs2071128 also significantly improved the model (P=1.49E-05), providing further evidence that variants in this region independently associated with the disease. Further addition of rs17422 showed marginal improvement to the model (P=0.043). These data, together with analysis of results reported previously by Kaufman et al (6) detailed in the discussion below, support the notion that independent effects exist in this region for disease susceptibility. Due to the limited power in detecting independent variants in a region in association studies, the detailed relationships among these variants, however, requires further replication in future studies.
Haplotype analysis was also performed using logistic regression on these three SNPs:
rs2071128, rs17422 and rs1059702, adjusting for possible differences among cohorts.
Analyses of males and females were done separately since treating males as homozygous and jointly analyzing samples would result in inflation of contributions from males. The result indicated that G-T-C haplotype formed by the three SNPs was the major protective haplotype with a combined OR of 0.76 and P value of 9.78E-23, while the A-C-T haplotype formed by the major alleles of the three SNPs was the major risk haplotype with a combined OR of 1.19 and P=2.78E-27 in female samples (Table 4) . Similar results were observed in male samples with slightly larger effect size on the two major haplotypes (Supplementary Material, Table S2 ). Haplotype association in different cohorts showed consistent results (Fig. 4) .
Differences in effect size for the X-linked susceptibility SNPs between females and males
Larger effect sizes, as measured by OR, were observed in males compared to females in all the susceptibility SNPs confirmed in this study (ORs are shown in Supplementary Material, Table S3 ). In order to further evaluate potential differences between females and males, heterozygous females were separately considered from homozygous females (Fig. 3, Supplementary Material , Table S3 ).
It can be seen that the ORs (■) for the homozygous females are similar to those in males (▲), which are much bigger (farther away from 1) than those when all female samples were considered(•) (Fig. 3, Supplementary Material , Table S3 ). This is consistent among different cohorts. This result suggested that the X-linked susceptibility variants identified here are not involved in escaping dosage compensation.
In order to test whether the observed differences in effect size between the genders is a characteristic of the X-linked variants or is applicable to other susceptibility SNPs, we examined SNPs in the established loci that showed consistent signals in our meta-analysis results (Supplementary Material, Fig. S2 ). The HLA region was not included in this estimation of genetic risk due to lack of clarity on independent signals, but preliminary data on selected SNPs in the HLA region showed similar differences between males and females.
Discussion
Through meta-analysis of the two existing GWASs on Chinese Han populations, and further replication on three additional cohorts from Hong Kong, Anhui, and Thailand totaling 5,373 cases and 9,166 controls matched geographically and ethnically, we have identified multiple variants associated with SLE with evidence of independent effects.
Rs7062536 is located in an intron of PRPS2 and is on the p arm of the chromosome, and is clearly an independent contributor to SLE susceptibility. PRPS2 was known to play a key role in the process of purine and pyrimidine synthesis (33) , with no known function to autoimmunity or other immunological processes. Further work will be needed to understand the biological mechanism of this genetic association. The SNP (rs3853839) in the 3' UTR of TLR7 reported earlier, which is on the same arm of the chromosome, had poor imputation quality (impute score <0.6) and this region was also poorly covered by the Illumina 610 Quad Beadchip used in GWAS stage in both Hong Kong and Anhui cohorts.
The other signals identified are highly complex, covering a 134 kb region on Xq28, and overlapping with eight genes from upstream of L1CAM to the 3'UTR of MECP2.
Independence tests using logistic regression provided evidence of independent effects at least for SNPs rs2071128, rs17422 and rs1059702, although the detailed nature of their contribution towards disease susceptibility remains to be determined.
In the study of Kaufman et al (6) , other than rs1059702 (IRAK1), which was considered to be the most likely causal variant, six more SNPs reached genome-wide significance based on the meta-analysis results of four different populations.
Furthermore, 27 SNPs showed suggestive association in one or more populations.
There seem to be population differences in association signals on the centromeric part of this large region, especially around NAA10, RENBP, and ARHGAP4 ( Fig. 1 and Fig.S3-Fig. S6 ). We included the three independent SNPs identified in this study and the six SNPs shown to be highly significant in the study of
Kaufman et al (6) , in addition to SNP rs1059702 that was highly significant in both studies. In European American (EA) samples, SNPs in the region of ARHGAP4-NAA10-RENBP showed as strong association signals as those in the IRAK1-MECP2 region. For example, rs2071129 in NAA10, rs13397 in TMEM187, and rs1059702 in IRAK1 had similar association P values and ORs (Table 1 of Kaufman et al (6)). There is only intermediate LD between these variants in (NAA10) and rs1059702 (IRAK1) in Table 1 (34) . No other correlation between genotypes of the identified SNPs and these three genes was observed. We also did not observe difference on expression levels of these three genes between males and females, consistent with the genetic findings showing no evidence of escaping dosage compensation for the susceptibility SNPs identified in this study.
eQTL analysis was also performed using public databases such as mRNA by SNP Browser v 1.0.1 (35) and Genevar (36) , and no statistically significant correlation was identified between these SNPs and the neighboring genes. Thus the mechanisms for the disease association for these two regions found in this study await further investigation.
The association in males observed in this study had much larger effect sizes than in females, which is consistent with a previous study on another X-linked susceptibility gene, TLR7 (5). We thus evaluated the cumulative genetic risk scores genome-wide between males and females using known associated SNPs in the autosomes.
Relatively higher genetic risk scores in males than in females were observed in both Hong Kong and Anhui GWAS data (Fig. 5) , which is consistent with the results from Hughes et al (31) . The results emphasized that a higher genetic predisposition might be required for males than for females to develop the disease. We also observed that the difference in genetic risk scores between males and females was much smaller for the Anhui cohort, as well as the total genetic risk explained by these genetic variants.
Potential explanation of the differences between the two studies includes possible differences in diagnosis ascertainment and disease severity. Smaller sample size for male cases could also be a major reason for the differences observed. As shown in Table S5 (Supplementary Material), the effective sample size for males was much smaller than that for females in both cohorts.
In conclusion, meta-analysis of GWAS data on Asian populations followed by replication identified association of variant in PRPS2 and the L1CAM-MECP2 region to SLE. We also showed evidence of association in the L1CAM-NAA10-TMEM187
regions independent of the effect from variants in IRAK1 and MECP2, a region reported in previous studies. There is no evidence of escaping XCI and dosage compensation for the SNPs identified in this study, as demonstrated by the higher effect size in males than in females (Fig. 3) . These findings indicate that X-chromosome susceptibility variants may have little contribution to the gender difference for this disease. However, it is possible that overexpression of other unknown susceptibility genes, or X-linked genes without susceptibility variants could contribute to the higher female prevalence of the disease. With the increasing availability of expression data, it will be interesting to systematically compare the expression levels of X chromosome genes between males and females in relevant cells in both SLE patients and healthy individuals.
Materials and Methods
Subjects
The samples included in the current study were collected from Hong Kong, Anhui, China, and Bangkok, Thailand (Supplementary Material, Table S4 All studies were approved by the corresponding institutional review boards from all the institutions involved.
Genome-wide genotyping and quality control
The two GWAS from Hong Kong and Anhui were conducted by Illumina 610-Quad Human Beadchip array (25, 30) . Quality control for X chromosome was preceded as follows: the X-linked SNP call rate for each individual was set at 90% as a cutoff.
Any sample with ambiguous gender was removed. Any SNP with missing call rate >10% was removed. Any SNP with allele frequency in healthy females smaller than 1% was removed. Any SNP that violated Hardy-Weinberg Equilibrium (HWE) (P<10 -4 ) was discarded. The two GWAS dataset were treated following the same procedure, resulting in 11,747 X chromosome SNPs, 1,047 cases and 1,205 controls from Anhui cohort, together with 11,850 X chromosome SNPs, 612 cases and 2193 controls from Hong Kong cohort being kept for further analysis.
Imputation
X chromosome specific imputation was done to obtain genotypes of additional SNPs using all the samples from 1000 Genome Project (released on September2013) as the reference for Hong Kong and Anhui data. IMPUTE2.1.1 was used to perform imputation. Only SNPs with an information score larger than 0.9 were considered for the further analysis.
Replication of candidate SNPs
There were two replication processes in this study. In the first stage of replication, 11
SNPs with a meta-analysis P_meta<1*10 -3 in were selected for replication using samples which are not included in GWAS discovery stage. Together with SNPs reported in previous paper (32) , SNPs were designed to be genotyped by MassARRAY iPLEX Gold system (Sequenom) on samples in HK_REP, AH_REP1
and TH_REP. SNPs that failed to be designed on Sequenom chip were genotyped by TaqMan assay (Life technologies). Ten SNPs with consistent association signals in the first stage of replication were selected for a second replication stage on samples from AHREP2. MassARRAY iPLEX GOLD system was adopted at this stage too.
Association Analysis
We used inverse variance method for the meta-analysis. First of all, we aligned each allele from different cohorts to the same strand according to the Human Genome reference sequence in NCBI (Genome Build 37.5). Then, in order to estimate joint effect of strand-aligned reference allele from two different cohorts, inverse variances were used as weights to combine the effect sizes ( i  ) of corresponding allele in independent studies. As shown in Equation (1), i indicates each independent study, Joint analysis of association, eliminating the influence of gender and population stratification was conducted using logistic regression among different cohorts and different stages of the replication studies. These two factors were utilized as discrete covariates in logistic regression to adjust for the real P value as shown in the Equation (2) . Here, COV1 and COV2 indicate gender and population factors, adjusting for the true value of  and corresponding P value. Samples from different cohorts were marked as discrete labels (which was approximately equivalent to running association tests in each stratum separately and then meta-analysing results using an independent-effects meta-analysis).
Tests of independent contributions toward disease associations for SNPs in a single locus were done using logistic regression too, adjusting for the effect of a specific SNP (COV snp ) in the same locus, while also taking into account differences among cohorts and gender s as shown in Equation (3).
SNPTEST v2.5β was used to perform the logistic regression tests in this study (23) .
Stepwise logistic regression was performed by SPSS 16.0. Briefly, variables were added to the logistic regression equation one at a time, using the statistical criterion of reducing the -2Log 10 Likelihood error for the included variables. After each variable was entered, each of the included variables was tested to see if the model would be better off if the variable were excluded.
Linkage disequilibrium patterns and values were obtained using HaploView (37) .
Cumulative Genetic risk score calculation
We examined all the SNPs in the established loci showing consistency signals in our meta-analysis results (P_meta<5×10 -8 or replicated by our previous study) (25) (26) (27) (28) (29) (30) .
For each of these loci, logistic regression was performed, adjusting for the effect from the best SNP in each individual locus to find potential independent variants. In total, thirty-two SNPs from twenty-three loci were considered.
The cumulative genetic risk scores were calculated following the equation from
Hughes et al (31) . Cumulative risk was calculated in each patient by summing the risk scores from all the 32 independent SNPs on autosomes Cumulative Genetic Risk Score= OR i = Odds ratio of a given effect N i = Number of risk alleles at a given SNP site
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